Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students (VR-BodySafe)

12 de novembro de 2026 atualizado por: Edanur Tar Bolacali, Kirsehir Ahi Evran Universitesi

The Effect of Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students on Awareness, Diagnosis and Reporting Attitudes: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn whether a virtual reality-supported child abuse and body safety education program improves fourth-year nursing students' awareness of child abuse and neglect, their ability to recognize its signs and risk factors, and their attitudes toward reporting it. The main questions it aims to answer are: - Do students who receive the program score higher in recognizing the signs and risks of child abuse and neglect than students who do not? - Do they have higher awareness of child abuse and neglect and more positive attitudes toward reporting child abuse? - Are these effects still present one month after the program ends? Researchers will compare an intervention group, which takes part in an 8-week face-to-face program (one 90-minute session per week) ending with a virtual reality simulation, with a control group that receives no training during the study. Control group students will be offered the same training after the study ends. Participants will: - Complete questionnaires before the program, after the program, and one month later - If assigned to the intervention group, attend weekly education sessions and take part in a short virtual reality simulation in week 8

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

Background: Nurses are often the first health professionals to see signs of child abuse and neglect, but nursing students report limited knowledge, limited clinical exposure and uncertainty about legal reporting duties. Technology-based and simulation-based education may help close this gap. Design and setting: Two-arm, parallel-group, pretest-posttest randomized controlled trial with a one-month follow-up, conducted at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University, Kirsehir, Turkiye. The study was approved by the Cankiri Karatekin University Health Sciences Ethics Committee (Meeting No. 33, 12 May 2026) and is funded by the Kirsehir Ahi Evran University Scientific Research Projects Coordination Unit (SYO.A3.26.006). Reporting will follow the CONSORT 2025 statement. Sample size: Calculated with G*Power 3.1.9.2 using Child Abuse and Neglect Symptoms and Risk Diagnosis Scale scores from a similar study (3.39 +/- 0.28 and 3.60 +/- 0.28; effect size 0.75, alpha 0.05, power 0.95), giving 96 students (48 per group). Allowing for attrition, 100 students (50 per group) will be enrolled. Randomization and allocation concealment: After baseline measurements, students will be assigned 1:1 to the intervention or control group by simple randomization using a computer-generated sequence (randomizer.org). Randomization will be performed by an independent researcher not involved in delivering the intervention, and the allocation list will be concealed from the research team until assignment. Masking: Because of the nature of the intervention, participants and educators cannot be masked. Data will be coded (e.g., Group A and Group B) and analyzed by an independent statistician unaware of group allocation. Intervention delivery: Seven weekly face-to-face modules use active learning techniques. In week 8, students take part in the virtual reality game "Look From My World", in which they experience, from a 7-year-old child's point of view, a child's attempt to disclose a body safety violation to a school nurse and compare an inappropriate and an appropriate nursing response. The scenario does not depict abuse. A structured PEARLS debriefing follows. Module content and the scenario were reviewed by experts and will be pilot-tested with nursing students before the trial. Data analysis: IBM SPSS Statistics 29.0. Group x time effects will be tested with two-way repeated measures ANOVA when parametric assumptions are met, or with non-parametric equivalents. Analysis will follow the intention-to-treat principle. The significance level is set at p < 0.05. Safety: Participants may stop the virtual reality application at any time without any consequence. Students with epilepsy or severe motion sickness are excluded. Psychological support and referral information are available during and after the sessions.

Tipo de estudo

Intervencional

Inscrição (Estimado)

100

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Fourth-year student at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University
  • Has completed the Child Health and Diseases Nursing (Pediatric Nursing) course
  • Has not previously attended a structured education program on child abuse and body safety
  • Volunteers to participate and signs the informed consent form
  • States that they can attend the education sessions and all measurements

Exclusion Criteria:

  • Has received certified training in child abuse, neglect or forensic nursing
  • Is actively working in an institution or project related to child abuse
  • Has a known health condition that may prevent virtual reality use (e.g., severe motion sickness or vertigo, epilepsy)
  • Did not complete the baseline measurements or completed the scales with substantial missing or invalid responses

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: VR-Supported Body Safety Education

Fourth-year nursing students who receive an 8-week face-to-face education program (one 90-minute session per week) on child abuse, neglect and body safety, ending with a virtual reality simulation in week 8.

An 8-week face-to-face program with one 90-minute session per week. Weeks 1-7 cover child maltreatment; child neglect and the nursing approach; types of child abuse (physical, emotional, sexual and cyber abuse); child abuse and the nursing approach, including documentation and legal reporting; interventions for preventing child abuse and neglect; and body safety education for teaching children self-protection skills (two sessions). Each module uses an active learning technique (station technique, six thinking hats, brainstorming, six action shoes, cooperative learning). In week 8, students complete the virtual reality game "Look From My World" (about 6 minutes), experiencing from a 7-year-old child's perspective a disclosure to a school nurse with an inappropriate and an appropriate nursing response, followed by a structured PEARLS debriefing.

Sem intervenção: Wait-list Control

Fourth-year nursing students who receive no training during the study and continue their usual curriculum. They will be offered the same program after the one-month follow-up measurement.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Recognition of Signs and Risks of Child Abuse and Neglect
Prazo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Symptoms and Risk Diagnosis Scale (Uysal, 1998), 67 items in 6 subscales rated on a 5-point Likert scale (21 items reverse-scored). Total score ranges from 67 to 335; higher scores indicate better recognition of the signs and risk factors of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Child Abuse and Neglect Awareness
Prazo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Awareness Scale, 20 case-based items in 4 subscales (physical, sexual and emotional abuse, and neglect) rated on a 5-point Likert scale. Total score ranges from 20 to 100; higher scores indicate greater awareness of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention
Attitudes Toward Reporting Child Abuse
Prazo: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Turkish version of the Healthcare Provider Attitudes Toward Child Maltreatment Reporting Scale (Singh et al., 2017; Turkish adaptation by Turan and Erdogan, 2019), 21 items rated on a 5-point Likert scale. Total score ranges from 21 to 105; higher scores indicate more positive, responsibility-oriented attitudes toward reporting child abuse.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

17 de novembro de 2026

Conclusão Primária (Estimado)

15 de janeiro de 2027

Conclusão do estudo (Estimado)

28 de fevereiro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

12 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de novembro de 2026

Primeira postagem (Real)

18 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • SYO.A3.26.006

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared because participants did not consent to data sharing and the dataset includes sensitive information about participants' own childhood experiences of abuse and neglect. Aggregate results will be published in a peer-reviewed journal.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .